| # | Drug | Count |
|---|---|---|
| 0 | DARBEPOETIN ALFA | 491 |
| 1 | DENOSUMAB | 210 |
| 2 | ALBUTEROL SULFATE | 150 |
| 3 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 139 |
| 4 | FLUTICASONE PROPIONATE AND SALMETEROL | 124 |
| 5 | ETANERCEPT | 86 |
| 6 | PAZOPANIB HYDROCHLORIDE | 79 |
| 7 | ENZALUTAMIDE | 68 |
| 8 | INSULIN GLARGINE | 67 |
| 9 | FUROSEMIDE | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | 1 | 0.0286 |
| 1 | DARBEPOETIN ALFA | 491 | 0.0091 |
| 2 | FONDAPARINUX SODIUM | 46 | 0.0057 |
| 3 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 4 | CUPRIC OXIDE | 2 | 0.0045 |
| 5 | PAZOPANIB HYDROCHLORIDE | 79 | 0.0029 |
| 6 | BELINOSTAT | 1 | 0.0028 |
| 7 | CARVEDILOL PHOSPHATE | 8 | 0.0027 |
| 8 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 139 | 0.0023 |
| 9 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 491 |
| 1 | Leukocyte Growth Factor [EPC] | 396 |
| 2 | RANK Ligand Inhibitor [EPC] | 210 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 150 |
| 4 | Benzodiazepine [EPC] | 88 |
| 5 | Corticosteroid [EPC] | 80 |
| 6 | Insulin Analog [EPC] | 78 |
| 7 | Atypical Antipsychotic [EPC] | 71 |
| 8 | Androgen Receptor Inhibitor [EPC] | 69 |
| 9 | Loop Diuretic [EPC] | 66 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 49 | 0.0395 |
| 1 | Erythropoiesis-stimulating Agent [EPC] | 491 | 0.0091 |
| 2 | Leukocyte Growth Factor [EPC] | 396 | 0.0028 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 28 | 0.0018 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 9 | 0.0015 |
| 5 | Provitamin D2 Compound [EPC] | 33 | 0.0011 |
| 6 | RANK Ligand Inhibitor [EPC] | 210 | 0.0010 |
| 7 | Iron Chelator [EPC] | 28 | 0.0010 |
| 8 | Androgen Receptor Inhibitor [EPC] | 69 | 0.0009 |
| 9 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |